Ulcerative Colitis Clinical Trials in New York

Showing 861-880 of 884 trials

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

NCT00779688

This registry will collect data from patients routinely undergoing an ERCP and Cellvizio endomicroscopy procedure (and optionally an additional cholangiopancreatoscopy procedure) due to suspected pancreatic or bile duct cancer. The objective is to determine if endomicroscopy images collected using the marketed Cellvizio device may help endoscopists more accurately diagnose, in conjunction with traditional tissue sampling techniques, whether a suspected lesion is malignant or benign.

Pancreatic CancerBile Duct Cancer

Mauna Kea Technologies130 participantsStarted Nov 2008

Aurora, Colorado, United States • Boston, Massachusetts, United States • New York, New York, United States +3 more locations

COMPLETEDPhase 1< 1 mile

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

NCT00295282

This is a Phase I dose-escalation study of MDX-1100. patients with ulcerative colitis will be enrolled into one of four dose cohorts, to receive of MDX-1100 at 0.3, 1.0, 3.0 or 10mg/kg. Three to six patients will be enrolled at each dose level, starting at the lowest dose level, for a maximum of 24 patients to be enrolled into the study. The study is designed to establish the safety and tolerability of single doses of MDX-1100 administered in dose-escalating cohorts to patients with ulcerative colitis. Other study objectives include characterizing a pharmacokinetic profile and pharmacodynamic effects of MDX-1100 and determination of immunogenic response to MDX-1100.

Ulcerative Colitis

Bristol-Myers Squibb24 participantsStarted Jan 2006

Los Angeles, California, United States • Largo, Florida, United States • Chevy Chase, Maryland, United States +2 more locations

A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

Ulcerative Colitis Trials in Other Cities

Quality Of Life in Patients With Malignant Biliary Obstruction

Basiliximab in Moderate to Severe Ulcerative Colitis

Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

A Comparison of SYMBICORT® pMDI With Formoterol Turbuhaler® in Subjects With COPD

Efficacy of SNX-1012 in the Treatment of Oral Mucositis

Chromium Effects on Insulin and Vascular Function in People at Risk for Diabetes

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPD

Quality of Life in Pediatric Inflammatory Bowel Disease

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Insertion of an Intrauterine Device (IUD) After Medical Abortion

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

A Study in Type 1 Gaucher Patients to Evaluate the Pharmacokinetics, Safety and Pharmacodynamics of AT2101

Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active Control

A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI

Other Conditions in New York